Confectionery Products as Delivery Systems for Flavors, Health, and Oral-Care Actives

Encapsulation and Controlled Release Technologies in Food Systems

Volumn , Issue , 2007, Pages 171-200

  Lakkis, Jamileh M ^a  

^a NONE

Author keywords

Confectionery products; Delivery systems; Flavors; Health; Oral care actives

Indexed keywords

HEALTH;

CONFECTIONERY PRODUCTS; DELIVERY SYSTEMS; ORAL CARE;

FLAVORS;

EID: 84909993253     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470277881.ch8     Document Type: Chapter

References (121)

1. Andersen, C. 2004. Method of preparation of chewing gum with customer acceptable taste. US patent 0028772 A1.
2. Anderson, M.P. 1992. Lack of bioequivalence between disulfiram formulations. Acta Psychiatr. Scand. Suppl. 86: 31-35W.
3. Anlar, S., Capan, Y., Guven, O., Gogus, A., Dlarara, T. and Hincel, A.A. 1984. Formulation and in-vitro in-vivo evaluation of buccoadhesive morphine sulfate tablet. Pharm. Res. 11: 231-236.
4. Assev, S. and Rølla, G. 1986. Sorbitol increases the growth inhibition of xylitol on Strep. mutans OMZ 176. Acta Path. Microbiol. Immunol. Scand. Sect. B. 94: 231-237.
5. Barklow, D.G., Chapdelaine, A.H. and Dzjia, M.R. 2002. Pullulan-free edible film compositions and methods of making the same. US Patent 0131990 A1.
6. Bealin-Kelley, F.J., Hanke, B. and Nienaber, P. 2002. Throat soothing compositions. US Patent 6432441 B1.
7. Beckett, A.H. and Moffat, A.C. 1969. The influence of substitution in phenylacetic acid on their performance in the buccal absorption test. J. Pharm. Pharmacol. 21: 139S-143S.
8. Benowitz, N., Jacob, P. and Savanapridi, C. 1987. Determination of nicotine intake while chewing nicotine polacrilex gum. Clin. Pharmacol. Ther. 41: 467-473.
9. Berridge, M.J. and Oschman, T.L. 1972. In Transporting Epithelia, Academic Press, New York and London.
10. Blanchette, J., Kavimandan, N. and Peppas, N.A. 2004. Principles of transmucosal delivery of therapeutic agents. Biomed. Pharmacother. 58: 142-151.
11. Bouckaert, S., Lefebvre, R.A. and Remon, J-P. 1993. In vitro/in vivo correlation of the bioadhesive properties of a buccal bioadhesive miconazole slow-release tablet. Pharm. Res. 10(6): 853-856.
12. Broderick, K.B. and Record, D.W. 1992. Gum composition containing dispersed porous beads containing active chewing gum ingredients and method. US patent 5139787.
13. Bunczek, M.T. and Urnezis, P. 1993. Aspartame stability in chewing gum using an acid gelatin system. US Patent 5192561.
14. Channer, K.S. and Roberts, C.J.C. 1985. Effect of delayed esophageal transit on acetominophen absorption. Clin. Pharmacol. Ther. 37: 72-76.
15. Chauncey, H.H., Lionetti, F., Winer, R.A. and Lisanti, V.F. 1957. Enzymes of human saliva I. The determination, distribution and origin of the whole saliva enzymes. J. Dent. Res. 33: 321-334.
16. Chow, L.C. and Takagi, S. 2001. Calcium phosphate hydroxyapatite precursor and methods for making and using the same. US Patent 6325292 B1.
17. Choi, H-G. and Kim, C-K. 2000. Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J. Control. Release 68: 397-404.
18. Christup, L.L. and Møller, N. 1986. Chewing gum as a drug delivery system. I. in vitro simulation of human masticatin and influence of formulation upon the release rate of a water soluble drug. Arch. Pharm. Chem. Sci. Edu. 14: 30-36.
19. Christup, L.L., Davis, S.S. and Frier, M. 1990. Deposition of a model substance 99mTcE-HIDA, in the oral cavity after administration of lozenges, chewing gum and sublingual tablets. Int. J. Pharm. 66: 169-174.
20. Christup, L.L., Rasmussen, S.N. and Rassing, M.R. 1988a. Chewing gum as a drug delivery system. Proc. 3rd Int. Conf. Drug Absorpt. Edinburgh.
21. Christup, L.L., Bonde, J., Eriksen, H., Rasmussen, S.N., Rasig, M.R. and Simonsen, K. 1988b. Chewing gum as a drug delivery system. III. Bioavailability of salicylamide administered in tablets and chewing gum. Farmaci. Sci. Ed. 16: 6-14.
22. Clark, J.C. and Shen, C.A. 2004. Fast flavor release coating for confectionery. US Patent 0175489 A1.
23. Collins, L.M.C. and Dawes, C. 1987. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J. Dent. Res. 66: 1300-1302.
24. Commission of the European Communities. 1991. CPMP list of allowed terms for the pharmaceutical dosage form, route of administration, container, closure and administration devices, III/3593/91.
25. Curatolo, W. 1987. The lipoidal permeability barriers of the skin and alimentary tract. Pharm. Res. 4: 271-277.
26. De Vries, M.E, Boddé, H.E. and Junginer, H.E. 1991. In vitro and in vivo adhesion performance of buccal mucoadhesive patches. In thesis: De Vries, M. Buccal drug absorption and development of mucoadhesive polymer systems, State University of Leiden, The Netherlands.
27. Dobrozsi, D.J. 2003. Oral liquid mucoadhesive compositions. US Patent 6638521.
28. Donbrow, M. and Freidman, M. 1974. Permeability of films of ethyl cellulose and PEG to caffeine. Commun. J. Pharm. Pharmac. 26: 148-150.
29. Eichman, J.D. 1997. Mechanistic studies on effervescent permeability enhancement; PhD dissertation, University of Wisconsin-Madison.
30. Evered, D.F. and Mallett, C. 1983. Thiamine absorption across human buccal mucosa in vivo. Life Sci. 32: 1355-1358.
31. Evered, D.F, Sadooght-Abasian, F. and Patel, P.D. 1980. Absorption of nicotinic acid and nicotinamide across human buccal mucosa in vivo. Life Sci. 27: 1649-1651.
32. Fernö, O. 1973. A substitute for tobacco smoking. Psychopharmacologia 31: 201-204.
33. Fromter, E. and Diamond, J. 1972. Route of passive ion permeation in epithelia. Nature New Biol. 235: 9-13.
34. Gandhi, R.E. and Robinson, J.R. 1988. Bioadhesion in drug delivery. Ind. J. Pharm. Sci. 50: 145-152.
35. Gelski, J. 2006. Tea's weight loss potential cited as additional benefits. Food Business News 28: 38-40.
36. Gudas, V.V., Reed, M.A., Schnell, P.G., Tyrpin, H.T., Russell, M.P. and Witkewitz, D.L. 2000. Method of controlling release of caffeine in chewing gum. US Patent 6165516.
37. Guo, J-H. 1994. Investigating the surface properties and bioadhesion of buccal patches. J. Pharm. Pharmacol. 46: 647-650.
38. Haines, H.G. 2004. A pilot study evaluating the bioavailability and absorption rates of two vitamin B12 preparations in normal human subjects. Health Plus International, Inc. (study protocol # HPI-NF-B12-1).
39. Harris, D. and Robinson, J.R. 1992. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 81: 1-10.
40. Hayward, A.F. 1979. Membrane-coating granules. Int. Rev. Cytol. 59: 97-127.
41. Hutchinson, K.G. and Garnett, K.R. 1999. Method of making water-based beverages. US 5871789.
42. Jacob, J.S., Mathiowitz, E., Nangia, A., Shaked, Ze'ev and Moslemy, P. 2006. Controlled regional oral delivery. US Patent 0045865 A1.
43. Jenkins, G.N. and Edgar, W.M. 1989. The effect of daily gum-chewing on salivary flow rates in man. J. Dent. Res. 5: 786-790.
44. Johnson, S. and Yatka, R.J. 2000. Method of making chewing gum products containing perillratine. US patent 6159509.
45. Johnson, S., Sheldon, G. and Greenberg, M.J. 2004. Oral products containing novel flavor composition. US Patent 0141927.
46. Kaaber, S. 1973. Studies on the permeability of human oral mucosa VI. The mucosal transport of water, sodium and potassium under varying osmotic pressure. Acta Odont. Scand. 31: 307-316.
47. Kaaber, S. 1974. The permeability and barrier functions of the oral mucosa with respect to water and electrolytes. Acta Odontol. Scand. 32 (Suppl 66): 26.
48. Kahn, C.R. and Shechter, Y. 1991. "Oral hypoglycemic agents and the pharmacology of the endocrine pancreas". In Theodor W.R., Alan, S.N., Taylor, P. and Gilman, A.G., (Eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed., New York, NY: McGraw Hill: 1484.
49. Kamimori, G.H., Karyekar, C.S., Ottersetter, R., Cox, D.S., Balkin, T.J., Belenky, G.L. and Eddington, N.D. 2002. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Int. J. Pharm. 234(1-2): 159-167.
50. Kanwar, Y.S., Linker, A. and Farquhar, M.G. 1980. Increased permeability of the glomerular basement membrane to ferritin after removal of glucosaminoglycans (heparin sulfate) by enzyme digestion. J. Cell Biol. 688-693.
51. Karles, G., Garthaffner, M., Juper, R., Kellog, D. and Skinner, I. 2006. Flavor capsule for enhanced flavor delivery in cigarettes. US Patent 082529 A2.
52. Kaufmann, K. 2003. Hard candy with plaque-neutralizing effect comprising alkali metal monophosphate. US Patent 6582731 B1.
53. Kayane, S., Tsutomu, I., Iwase, T. and Miura, Y. 2003. Throat care agents. US Patent 0170322 A1.
54. Lakkis, J. 2006. Roadmap to development of healthy food products via encapsulation and controlled release technologies. Paper presented at the Controlled Release Society Meeting, July 25, 2006, Vienna, Austria.
55. Lakkis, J. and Wong, S. 2007. Multilayered confectionery product with controlled release teeth remineralization actives (patent submitted).
56. Leach, S.A., Lee, G.T.R. and Edgar, W.M. 1989. Remineralization of artificial caries-like lesions in human enamel in situ by chewing sorbitol gum. J. Dent. Res. 68(6): 1064-1068.
57. Lee, R.E. 2004. Effervescent tablets: Key facts about a unique effective dosage form. Tablets and Capsules. July:40-45.
58. Lesch, C.A., Squier, C.A., Cruchley, A., Williamson, D.M. and Speight, P. 1989. The permeability of human oral mucosa and skin to water. J. Dent. Res. 68: 1345-1349.
59. Lindqvist, L. and Augustinsson, K.B. 1975. Esterases in human saliva. Enzyme 20: 277-291.
60. Lombardy, C.M., Lombardy, D.R. and Liebrecht, J.W. 2001. Effervescent chewing gum. US patent 6235318 B1.
61. Macknight, A.D.L. and Leader, J.P. 1983. Intra- and trans-epithelial analytical techniques. CRC Crit. Rev. Clin. Lab. Sci. 18: 339-395.
62. Manning, A.S. and Evered, D.F. 1976. The absorption of sugars from the human buccal cavity. Clin. Sci. Molec. Med. 51: 127-132.
63. Mazurek, P.M., Reed, M. and Broderick, K. 2000. Chewing gum with dental benfits including calcium in a food grade acid. WO 00/62762.
64. McGrew, G.N., Maxwell, J.R., Tyrpin, H., Greenberg, M.J. and Record, D.W. 2006. Chewing gum that provides breath freshening characteristics. US patent 7087255 B2.
65. Merritt, C., Wingerd, W.H. and Keller, D.J. 1985. Encapsulated flavorant material, methods for its preparation and food and other compositions incorporating the same. US Patent 4515769.
66. Mulry, J.T. 1988. Nicotine gum dependency: A positive addiction. Drug Intell. Clin. Pharm. 22: 313-314.
67. Nicolazzo, J.A., Reed, B.L. and Finnin, B. 2003. Assessment of the effects of sodium dodecyl sulfate on the buccal permeability of caffeine and estradiol. J. Pharm. Sci. 93(2): 431-440.
68. Nuernberg, B. and Brune, K. 1989. Buffering the stomach content enhances the absorption of diflunisal in man, Biopharm. Drug Dispos. 10: 377-387.
69. Odumusu, A. and Wilson, C.W. 1977. The buccal absorption of ascorbic acid and its passage through lipoid membrane. Int. J. Vitam. Nutr. Res. 47: 135-144.
70. Ozaki, Y. and Miyake, T. 1995. Pullulan binder and its uses. US Patent. 5411945.
71. Paetau, I., Rao, D., Wiley, E.R., Brown, E.D. and Clevidence, B.A. 1999. Carotenoids in human buccal mucosa cells after 4 wk of supplementation with tomato juice or lycopene supplements. Am. J. Clin. Nutr. 70: 490-494.
72. Pang, K.S. 2003. Modeling of intestinal drug absorption: Roles of transporters and metabolic enzymes (for the Gillette review series). Drug Metab. Dispos. 31: 1507-1519.
73. Pather, S.I., Robinson, J.R., Eichman, J.D., Khankai, R.K., Hontz, J. and Gupta, S.V., 2002. Effervescent drug delivery systems for oral administration. US Patent 6391335.
74. Pedersen, M. and Rassing, M.R. 1990. Miconazole and miconazole nitrate chewing gum as drug delivery systems-a practical application of solid dispersion technique. Drug Dev. Ind. Pharm. 16(1): 55-74.
75. Rassing, M.R. 1994. Chewing gum as a drug delivery system. Adv. Drug Deliv. Rev. 13: 89-121.
76. Ream, R., Greenberg, M., Wokas, W. and Corriveau, C.L. 2003. Over-coated chewing gum formulation. US Patent 20030313 A1.
77. Ream, R.L., Corriveau, C.L., Graff, G. and Matulewicz, L. 2001. Over-coated chewing gum formulations including tabeleted center. US Patent 6322806 B1.
78. Rivier, V. 2005. Confectionery product containing functional ingredients. EP 1280414 B1.
79. Rojanasakul, Y., Wang, L-Y., Bhat, M., Glover, D.D., Malange, C.J. and Ma, J.K.H. 1992. The transport barrier of epithelia: A comparative study of membrane permeability and charge selectivity in the rabbit. Pharm. Res. 9: 1029-1034.
80. Rutherford, H.J., Desai, N., McDermott, K. and Wiener, C. 1992. Chewing gum containing compositions for controlled release of flavor-bearing substances and process for producing same. EP 0502750 A1.
81. Sadoogh-Abasian, F. and Evered, D.F. 1979. Absorption of vitamin C from the human buccal cavity. Br. J. Nutr. 42: 15-20.
82. Sadoogh-Abasian, F. and Evered, D.F. 1980. Absorption of nicotinic acid and nicotinamide across human buccal mucosa. Life Sci. 27: 1649-1651.
83. Savage, W.D., Schnell, P.G., Aumann, R.A. and Yatka, R.J. 2002. Chewing gum formulations including encapsulated aspartame and sodium phosphate. US Patent 0142068 A1.
84. Schanker, L.S. 1964. Physiological transport of drugs. Adv. Drug Res. 1: 71-106.
85. Semple, W.F. 1869. Improved chewing gum. US Patent 98304.
86. Sexton, D. and Lakkis, J. 2003. Encapsulated alcoholic beverages and method of making same. US Patent 750802.
87. Sharma, S.C. and Yang, K.Y. 1986. Chewing gum compositions containing novel sweetener delivery systems and method of preparation. US patent 4597970.
88. Siegel, I.A. 1984. "Permeability of the oral mucosa". In Meyer, J., Squier, C.A. and Gerson S.J. (Eds) The Structure and Function of Oral Mucosa. Oxford, Pergamon Press. 95-108.
89. Siegel, I.A., Hall, S.H. and Stambaugh, R. 1971. "Permeability of the oral mucosa". In Squier C.A. and Meyer J. (Eds) Current concepts of the histology of oral mucosa. Charles C. Thomas, Springfield. 274-286
90. Silagy, C., Lancaster, T., Stead, L., Mant, D. and Fowler, G. 2002. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 4: CD000146.
91. Song, J.H. and Copper, C.M. 1992. Gradual release structures for chewing gum. US patent 5165944.
92. Song, J.H. and Courtwright, S.B. 1992. Flavor releasing structures for chewing gum. US Patent 5128155.
93. Song, J.H., Sundstrom, E., Record, D., Townsend, D., Broderick, K.B. and Schnell, P. 1992. Gum composition containing dispersed porous beads containing active ingredients and method. US patent 5154927.
94. Squier, C.A. and Hall, B. 1985. The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier. J. Invest. Dermatol. 84: 176-179.
95. Squier, C.A., Johson, N.W. and Hopps, R.M. 1976. Human Oral mucosa: Development, Structure and Function. Blackwell Scientific, Oxford.
96. Squier, C.A. and Kremer, M.J. 2001. Biology of oral mucosa and esophagus. J. Natl. Cancer Inst. Monograph 29: 7-15.
97. Squier, C.A. and Wertz, P.W. 1996. Structure and function of the oral mucosa and implications for drug delivery, pp. 1-26, in Oral Mucosal Drug Delivery, Rathbone, M.J. (Ed.), Marcell Dekker, Inc. New York, NY.
98. Stevenson, N.R. 1974. Active transport of L-ascorbic acid in the human ileum. Gastroenterology 67: 952-956.
99. Sunohara, H., Kamaguchi, R., Kagawa, M., Nishikawa, M. and miura, Y. 2002. Multilayered soft capsule for eliminating bad breath and process for producing the same. US Patent 6426089 B1.
100. Syed, S.A., Kamimori, G., Kelley, W. and Eddington, N.D. 2005. Multiple dose pharmacokinetics of caffeine administered in chewing gum to normal healthy volunteers. Biopharm. Drug Dispos. 26(9): 403-409.
101. Tabak, L.A., Levine, M.J., Mendell, I.D. and Ellison, S.A. 1982. Role of salivary mucins in the protection of the oral cavity. J. Oral Pathol. 11: 1-7.
102. Tan, S.C. 1976. Human saliva esterases. Genetic studies. Human Hered. 26: 207-216.
103. Tanner, K. and Shelley, R.S. 1996. Fill compositions for soft elastic gel capsules. US patent 5569466.
104. Tucker, I.G. 1988. A method to study the kinetics of oral mucosal drug absorption from solutions. J. Pharm. Pharmacol. 40: 679-683.
105. Tuovinen, L., Peltonen, S. and Järvinen, K. 2003. Drug release from starch-acetate films. J. Control. Release 91: 345-354.
106. Tutuncu, N.P., Hartunian, S., Bratton, J.A. and Stanton, K.J. 2003. Confectionery product having a salivation region and an oral comfort region. US Patent 0118628 A1.
107. Veillard, M.M., Longer, M., Martens, T.W. and Robinson, J.R. 1987. Preliminary studies of oral mucosal delivery of peptide drugs. J. Control. Release 6: 123-131.
108. Virgallito, M.T. and Zhang, J. 2006. Edible film containing food acid. US Patent 0035008 A1.
109. Weatherell, J.A., Robinson, C. and Rathbone, M.J. 1994. Site-specific differences in the salivary concentration of substances in the oral cavity-implications for the etiology of oral disease and local drug delivery. Adv. Drug Del. Rev. 13: 23-42.
110. Weatherell, J.A., Strong, M., Robinson, C., Nakagi, H. and Ralph, J.P. 1984. Migration of fluoride in the mouth. Caries Res. 18: 348-353.
111. Weatherell, J.A., Strong, M., Robinson, C., Nakagi, H. and Ralph, J.P. 1989. Retention of glucose in oral fluid at different sites in the mouth. Caries Res. 23: 399-405.
112. Wennerholm, K. and Emilson, C.-G. 1989. Effect of sorbitol- and xylitol-containing chewing gum on salivary microflora, saliva, and oral sugar clearance. Scand. J. Dent. Res. 97: 257-262.
113. Wertz, P.W. and Downing, D.T. 1983. Ceramides of pig epidermis: Structure determination. J. Lipid Res. 24: 759-765.
114. Winston, A. and Usen, N. 2002. Products and methods for the remineralization and prevention of demineralization of teeth. US Patent 6451290 B2.
115. Witzel, F., Wayne, J.P., Warren, C., Donald, A. and Mackay, M. 1980. Chewing gum capable of releasing finely divided water-insoluble materials therefrom. US Patent 4238475.
116. Wolf, F.R., Mcgrew, G.N. and Tyrpin, H.T. 2005. Chewing gum containing controlled release acyclic carboxamides. US 0082271 A1.
117. Wolfson, P. 2002. Herbal composition for improving oral hygiene, for providing local anesthesia, for use as an oral sensate, flavor enhancer and potentiator, and methods of using same. US patent 0122778 A1.
118. Wong, F.W., Yuen, K.H. and Peh, K.K. 1999. Formulation and evaluation of controlled release Eudragit buccal patches. Int. J. Pharm. 178(1): 11-22.
119. Wonschik, J., Machinek, A. and Koschorreck, C. 2005. Coated spherical: Seamless filled capsules. WO 2005/077521 A1.
120. Woodford, W. and Lesko, L.J. 1981. Relative bioavailability of aspirin gum. J. Pharm. Sci. 70: 1341-1343.
121. Yang, J. H. 2005. Gelatin soft capsule having the properties of removal of oral smell and cleaning of oral cavity. US Patent 6852309 B2.